NOLA (NeuWave Observational Liver Ablation) Registry

Stopped early

Conditions studied: Cancer of the Liver, Liver Cancer, Neoplasms, Liver

In brief

This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.

Key facts

Study ID

NCT04107766

Run by

Ethicon, Inc.

People needed

1254

Starts

2020-01-15

Expected to finish

2025-06-18

Last updated by the study team

2026-04-17

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who underwent or are scheduled to undergo a microwave ablation of one or more liver lesions with the NEUWAVE Microwave Ablation System per the device's Instructions for Use (IFU).
• Patients with signed informed consent (or waiver approved by IRB/EC) who are willing to comply with the assessment schedule, and willing to have data included in the database.
• Patients greater than or equal to 22 years old at the time of informed consent (or waiver approved by IRB/EC).

You may not qualify if…

• Patients with a life expectancy of less than 1 year, in the opinion of the treating physician.
• Use of microwave ablation purely as a transection tool, rather than focused liver lesion ablation.
• Patient is currently participating, or planning to participate, in another NeuWave/Ethicon-funded clinical trial or registry studying microwave ablation in the liver. Note: roll-over patients from previous NeuWave trials are permitted.

Where it is running

• Loma Linda University Medical Center — Loma Linda, California, United States
• Cedars Sinai Medical Center — Los Angeles, California, United States
• David Geffen School of Medicine at UCLA — Los Angeles, California, United States
• Sutter Institute for Medical Research — Sacramento, California, United States
• Olive View UCLA — Sylmar, California, United States
• Mayo Clinic — Jacksonville, Florida, United States
• Sarasota Memorial Hospital — Sarasota, Florida, United States
• ICAHN School of Medicine at Mount Sinai — New York, New York, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Thomas Jefferson University — Philadelphia, Pennsylvania, United States
• MD Anderson Cancer Center — Houston, Texas, United States
• University of Virginia — Charlottesville, Virginia, United States
• University of Washington Medical Center — Seattle, Washington, United States
• University of Wisconsin At Madison — Madison, Wisconsin, United States
• The First Affiliated Hospital, Sun Yat-sen University — Guangzhou, Guangdong, China
• Renji Hospital, Shanghai Jiao Tong University School of Medicine — Shanghai, China
• Hôpital Européen Georges-Pompidou — Paris, France
• Tenon Hospital — Paris, France
• University Hospital Regensburg — Regensburg, Germany
• VUMC Amsterdam — Amsterdam, Netherlands
• University Medical Center Goningen — Groningen, Netherlands
• Radboud UMC — Nijmegen, Netherlands
• Singapore General Hospital — Singapore, Singapore
• Tan Tock Seng Hospital — Singapore, Singapore
• Seoul National University Bundang Hospital (SNUBH) — Seongnam-si, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.